Skip to main content

Table 4 Inter-rater reliability for PHQ-9 and FIBSER

From: The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase

PHQ-9

Item 1 (anhedonia)

0.953 (0.915 to 0.978)

 

Item 2 (depressed mood)

1.000 (−)

 

Item 3 (sleep problem)

1.000 (−)

 

Item 4 (anergia)

1.000 (−)

 

Item 5 (appetite problem)

0.992 (0.985 to 0.996)

 

Item 6 (guilt feelings)

1.000 (−)

 

Item 7 (concentration problem)

0.984 (0.970 to 0.993)

 

Item 8 (psychomotor symptoms)

1.000 (−)

 

Item 9 (suicidal wishes)

1.000 (−)

 

Total score

0.998 (0.996 to 0.999)

FIBSER

Item 1 (adherence)

1.000 (−)

 

Item 2 (frequency of side effects)

1.000 (−)

 

Item 3 (strength of side effects)

1.000 (−)

 

Item 4 (burden of side effects)

0.996 (0.993 to 0.998)